Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Reggie Groves, CEO, REVA Medical Inc
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Reva develops bioresorbable coronary scaffolds for the treatment of cardiovascular disease.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Over $6B assets under management, 31 IPOs, and 80+ acquisitions|Rodolfo Gonzalez,General Partner,Foundation Capital
00:00:00
Paradigm Biopharma – executive interview - Paul Rennie, CEO, co-founder and chairman, Paradigm Biopharmaceuticals Ltd
00:10:00
Jonathan Satchell, CEO of Learning Technologies Group PLC, discusses the company's half-year results for the six months ended 30 June 2021 in an interview with Proactive.
00:10:00
A Day in the Life of a Fund Manager: Inside M&G with Eva Sun-Wai
00:10:00
The benefits for startups to raise funds from celebrity investors such as American actor|Keisuke Honda,Co-Founder,Dreamers VC
00:10:00
A company's financial performance speaks the volumes|Clara Brenner,General Partner, Urban Innovation Fund
00:00:00
Zirui Song, MD, PhD Associate Professor of Health Care Policy and Medicine, Department of Health Care Policy, Harvard Medical School; | Making Health Care More Sustainable and Equitable
00:10:00
What Sets Beacon Financial Strategies Apart: Insights from Founder Chip Hymiller | Chip Hymiller, Founder , Beacon Financial Strategies.
00:10:00
Blue Value Advisors: Your Guide from Business Assessment to Successful Exit
00:10:00
People have real doubts about democracy and strong men|Robert Kagan,Author,Brookings Institution
00:10:00
Debunking 3 Common Myths About Social Security | Brian A. Remson - Advanced Planning Team at Credent Wealth Management
00:10:00
Exploring Entrepreneurial Journeys and Industry Insights| Gilles Avenard , CEO, Acticor Biotech SA.